Immunotherapy for cancer is a strategy to fight against the disease, including approaches like immune checkpoint therapies targeting CTLA-4 and PD-1, along with adoptive T cell therapies such as chimeric antigen receptor T-cell (CAR-T) therapy [62]. This evidence concerns the gene PDCD1 and cancer.